Your session is about to expire
← Back to Search
Treatment for Syndrome (GEMINI Trial)
GEMINI Trial Summary
This trial will compare the clinical utility and economic outcomes of rapid whole genomic sequencing (WGS) versus a targeted genomic sequencing panel (GSP) on neonates and infants suspected of having a genetic disorder.
GEMINI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is there an age restriction that limits enrollment in this experiment?
"For this medical trial, patients must be between 1 Day and 1 Year years old."
Are new participants able to enroll in this experiment?
"As reported on clinicaltrials.gov, this study is no longer actively recruiting patients and was last updated on March 11th 2022. Nevertheless, 1 other trial is enrolling participants at the present moment."
How can I gain admittance to this clinical experimentation?
"This research is recruiting 400 infants aged between 24 hours and 12 months that have a pediatric genetic syndrome. Additionally, they must be under one year in corrected gestational age to qualify for the trial."
Are there multiple locations in the United States conducting this trial?
"A number of hospitals are contributing to this clinical trial, including the Cincinnati Children's Hospital Medical Center in Ohio, Icahn School of Medicine at Mount Sinai in New york City and Rady Children's Hospital - San Diego in California. Additionally, there are 6 other sites that are partaking in the study."
Share this study with friends
Copy Link
Messenger